Skip to main content

Advertisement

Log in

The Therapeutic Anticancer Potential of Marine-Derived Bioactive Peptides: A Highlight on Pardaxin

  • Published:
International Journal of Peptide Research and Therapeutics Aims and scope Submit manuscript

Abstract

The discovery of marine-derived compounds bloomed in recent years. Bioactive compounds can be extracted from marine creatures like seahorses, mollusks, aquatic plants, algae, or fishes. Numerous of these discovered compounds were proven with various therapeutic values, including antibacterial, antihypertensive, antioxidant, and anticancer properties. Pardaxin is one of the recently discovered bioactive peptides with dual antibacterial and anticancer effects. Pardaxin is a 33-amino acid peptide that is secreted by the Red Sea Moses, Pardachirus marmoratus, solely for defensive purposes. This peptide was determined as a cationic peptide that held an alpha-helical structure, and it is believed that these two characteristics contributed to the anticancer potential of pardaxin. Therefore, this article reviews the anticancer properties of pardaxin in terms of its cancer-killing mechanisms such as apoptosis, cell cycle arrest, and cell lysis. Besides, we also reviewed other potent therapeutic applications of pardaxin, including the use of pardaxin as an immunotherapy agent, drug carrier, and in cancer vaccines. This review aims to encourage the use of pardaxin as an anticancer agent in the medicinal field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

Not applicable.

Abbreviations

UNESCO:

United Nations Educational, Scientific and Cultural Organization

ACE:

Angiotensin I-converting enzyme

HPLC:

High-performance liquid chromatography

PI3K:

Phosphatidylinositol 3-kinase

Akt:

Protein kinase B

TPA:

2-O-tetradecanoylphorbol-13-acetate

MMP:

Metalloproteinase

NF:

Nuclear factor

AR:

Androgen receptor

AAPH:

2,2‐Azobis hydrochloride

ROS:

Reactive oxygen species

mTOR:

Mammalian target of rapamycin

ERK:

Extracellular-signal regulated kinase

HA:

Hydroxyapatite

T2DM:

Type 2 diabetes mellitus

NMR:

Nuclear magnetic resonance

POPC:

1-Palmitoyl-2-oleoylphosphatidylcholine

DMPC:

Dimyristoylphosphatidylcholine

POPE:

1-Palmitoyl-2-oleoyl-phosphatidylethanolamine

POPG:

1-Palmitoyl-2-oleoyl-phosphatidylglycerol

MD:

Molecular dynamics

DPPC:

1,2-Dipalmitoylphosphatidylcholine

Bcl-2:

B-cell lymphoma 2

UPR:

Unfolded protein response

JNK:

C-Jun N-terminal kinase

PERK:

Protein kinase RNA-like endoplasmic reticulum kinase

eIF2a:

Eukaryotic initiation factor 2

CHOP:

C/EBP homologous protein

AIF:

Apoptosis-inducing factor

RhoGDI:

Rho GDP-dissociation inhibitor

LC:

Light chain

AVO:

acidic vesicular organelle

ER:

Endoplasmic reticulum

DC:

Dendritic cell

MHC:

Major histocompatibility complex

NO:

Nitric monoxide

MCP-1:

Monocyte chemoattractant protein-1

IL:

Interleukin

NK:

Natural killer

VEGF:

Vascular endothelial growth factor

PLA2:

Phospholipase A2

HT:

5-Hydroxytryptamine

Na + :

Sodium ion

K + :

Potassium ion

ATPase:

Adenosine triphosphatase

References

Download references

Acknowledgements

This work was supported by Taylor’s University through its TAYLOR’S RESEARCH SCHOLARSHIP Programme.

Funding

This study was partially supported by Fundamental Research Grant Scheme (FRGS/1/2020/STG03/TAYLOR/03/1), Malaysian Ministry of Higher Education and Memory Cards Sdn Bhd (Grant number: MEMORYCARDS/2021/SBS/001).

Author information

Authors and Affiliations

Authors

Contributions

YHW drafted and edited the manuscript. SRW edited the manuscript. SHL conceived, reviewed and edited the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sau Har Lee.

Ethics declarations

Conflict of interests

The authors have no competing interests to declare that are relevant to the content of this article.

Research Involving Human and Animal Rights

Nor applicable.

Ethical Approval and Consent to Participate.

Not applicable.

Consent for Publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, Y.H., Wong, S.R. & Lee, S.H. The Therapeutic Anticancer Potential of Marine-Derived Bioactive Peptides: A Highlight on Pardaxin. Int J Pept Res Ther 29, 90 (2023). https://doi.org/10.1007/s10989-023-10562-x

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10989-023-10562-x

Keywords

Navigation